Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Repligen Corp (RGEN)

Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,280,343
  • Shares Outstanding, K 56,331
  • Annual Sales, $ 738,260 K
  • Annual Income, $ 48,890 K
  • EBIT $ 55 M
  • EBITDA $ 151 M
  • 60-Month Beta 1.15
  • Price/Sales 8.40
  • Price/Cash Flow 32.23
  • Price/Book 2.94

Options Overview Details

View History
  • Implied Volatility 54.33% (-5.44%)
  • Historical Volatility 43.24%
  • IV Percentile 81%
  • IV Rank 37.56%
  • IV High 84.92% on 04/07/25
  • IV Low 35.94% on 08/14/25
  • Expected Move (DTE 17) 7.74 (6.57%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 8
  • Volume Avg (30-Day) 225
  • Put/Call OI Ratio 1.39
  • Today's Open Interest 6,946
  • Open Int (30-Day) 7,957
  • Expected Range 110.09 to 125.56

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.38
  • Number of Estimates 5
  • High Estimate $0.41
  • Low Estimate $0.37
  • Prior Year $0.39
  • Growth Rate Est. (year over year) -2.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
109.66 +7.44%
on 03/27/26
129.00 -8.67%
on 03/10/26
-10.91 (-8.48%)
since 02/27/26
3-Month
109.66 +7.44%
on 03/27/26
175.77 -32.97%
on 01/06/26
-48.39 (-29.11%)
since 12/26/25
52-Week
102.96 +14.43%
on 04/07/25
175.77 -32.97%
on 01/06/26
-15.59 (-11.69%)
since 03/28/25

Most Recent Stories

More News
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know

RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know

ILMN : 123.26 (+2.03%)
EVH : 2.28 (+5.07%)
RGEN : 117.82 (+5.68%)
CRL : 172.50 (+8.00%)
RDNT : 55.89 (+0.27%)
1 High-Flying Stock with Solid Fundamentals and 2 We Avoid

1 High-Flying Stock with Solid Fundamentals and 2 We Avoid

HLT : 304.08 (+2.77%)
COST : 996.43 (-0.02%)
RGEN : 117.82 (+5.68%)
1 Cash-Heavy Stock to Target This Week and 2 We Question

1 Cash-Heavy Stock to Target This Week and 2 We Question

NTRA : 199.99 (+7.04%)
RGEN : 117.82 (+5.68%)
REAX : 2.50 (+3.73%)
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

RGEN : 117.82 (+5.68%)
2 Growth Stocks Set to Flourishand 1 We Turn Down

2 Growth Stocks Set to Flourishand 1 We Turn Down

FTAI : 245.00 (+7.10%)
RGEN : 117.82 (+5.68%)
PANW : 160.32 (+3.87%)
3 Profitable Stocks We Keep Off Our Radar

3 Profitable Stocks We Keep Off Our Radar

DHI : 137.22 (+3.54%)
RGEN : 117.82 (+5.68%)
NMRK : 14.99 (+2.11%)
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know

AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know

AMN : 18.34 (-2.08%)
EVH : 2.28 (+5.07%)
RGEN : 117.82 (+5.68%)
AMPH : 19.59 (+1.93%)
RDNT : 55.89 (+0.27%)
Repligen Corporation to Present at Upcoming March Conferences

WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating...

RGEN : 117.82 (+5.68%)
3 Healthcare Stocks We’re Skeptical Of

3 Healthcare Stocks We’re Skeptical Of

TNDM : 19.17 (-2.12%)
RGEN : 117.82 (+5.68%)
SEM : 16.29 (unch)
3 Reasons to Avoid RGEN and 1 Stock to Buy Instead

3 Reasons to Avoid RGEN and 1 Stock to Buy Instead

RGEN : 117.82 (+5.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Repligen Corporation is a leading provider of advanced bioprocessing technologies and solutions used by large biopharmaceutical companies and contract manufacturing organizations for manufacturing biologic drugs, such as monoclonal antibodies (mAbs) and gene therapies. Repligen earns revenues from the...

See More

Key Turning Points

3rd Resistance Point 125.50
2nd Resistance Point 121.77
1st Resistance Point 119.79
Last Price 117.82
1st Support Level 114.08
2nd Support Level 110.35
3rd Support Level 108.37

See More

52-Week High 175.77
Fibonacci 61.8% 147.96
Fibonacci 50% 139.37
Fibonacci 38.2% 130.77
Last Price 117.82
52-Week Low 102.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.